Combined oral contraceptives (COCs) induce several changes in the levels of coagulation
factors. The levels of procoagulant factors are often increased, while levels of anticoagulant …

Venous thromboembolism is a well-known complication of oral contraception and hormonal
replacement therapy. Inherited thrombophilia is viewed as an important determinant in …

The increased risk of venous thrombosis in women taking oral contraceptives (OCs) has
been recognized since the early 1960s. Finding hematologic links between OC use and …

Some observational studies have found a difference in the risk of nonfatal venous
thromboembolism (VTE) with low-dose, oral contraceptives (OCs) containing desogestrel …

Background More than 150 million women worldwide use oral contraceptives. Women with
inherited thrombophilia and carriers of certain thrombophilia gene variants, such as factor V …

Essentials• We performed a meta‐analysis on thrombosis risk in thrombophilic oral
contraceptive (COC)‐users.• The results support discouraging COC‐use in women with a …

The history of the association between oral contraceptive (OC) use and venous
thromboembolism (VT) began more than 35 years ago. Doctor Jordan, a general …

Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

Background Venous thromboembolism (VTE) is a complex multifactorial disease influenced
by genetic and environmental risk factors. An example for the latter is the regular use of …

Oral contraceptives (OCs) are used by many millions of healthy young women. Their ease of
use and efficacy against unwanted pregnancy has made them an indispensable part of …